Kemeny, Nancy Ellen

Publications

Sort by

Co-Author Network

selected publications

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 497
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2018 Academic Article GET IT
Times cited: 60
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer. Annals of surgical oncology. 2017 Academic Article GET IT
Times cited: 86
A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases. Current treatment options in oncology. 2017 Academic Article GET IT
Times cited: 8
Liver-directed therapy in metastatic colorectal cancer. Expert review of anticancer therapy. 2017 Information Resource GET IT
Times cited: 24
Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases. Journal of surgical oncology. 2016 Academic Article GET IT
Times cited: 12
Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2016 Academic Article GET IT
Times cited: 57
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma. PloS one. 2016 Academic Article GET IT
Times cited: 60
Applying tumor genotyping and new clinical approaches to the management of colorectal cancer. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?. Annals of surgery. 2015 Academic Article GET IT
Times cited: 188
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer. European journal of nuclear medicine and molecular imaging. 2015 Academic Article GET IT
Times cited: 15
Liver-directed conversion therapy in metastatic colon cancer. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Times cited: 2
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2015 Academic Article GET IT
Times cited: 4
Metastatic Colorectal Cancer to the Liver: Involve the Surgeon Early and Often. Annals of surgical oncology. 2015 Editorial Article GET IT
Times cited: 5
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Annals of surgery. 2015 Academic Article GET IT
Times cited: 228
Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 258
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. Annals of surgical oncology. 2015 Academic Article GET IT
Times cited: 85
RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2014 Academic Article GET IT
Times cited: 170
Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nature cell biology. 2014 Academic Article GET IT
Times cited: 137
Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA surgery. 2013 Academic Article GET IT
Times cited: 81
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clinical colorectal cancer. 2013 Academic Article GET IT
Times cited: 46
Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 48
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2013 Academic Article GET IT
Times cited: 52
Treatment of metastatic colon cancer: "the times they are A-changing". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Editorial Article GET IT
Times cited: 31
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 51
Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases. The breast journal. 2012 Academic Article GET IT
Times cited: 11
Meeting the biologic challenge of colorectal metastases. Clinical & experimental metastasis. 2012 Information Resource GET IT
Times cited: 45
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. Journal of the American College of Surgeons. 2012 Academic Article GET IT
Times cited: 80
Combining hepatic arterial infusion and systemic therapy: radiologic versus surgical approaches. Journal of vascular and interventional radiology : JVIR. 2012 Article GET IT
Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clinical colorectal cancer. 2012 Academic Article GET IT
Times cited: 87
Changing paradigms for liver resection of colorectal metastases. Annals of surgical oncology. 2012 Editorial Article GET IT
Times cited: 1
The adrenal gland: fascinating, but still many advances to be made. Journal of surgical oncology. 2012 Editorial Article GET IT
Times cited: 1
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 247
What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer. Journal of gastrointestinal oncology. 2012 Academic Article GET IT
Times cited: 26
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer. 2012 Academic Article GET IT
Times cited: 33
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Annals of surgery. 2011 Academic Article GET IT
Times cited: 105
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011 Academic Article GET IT
Times cited: 48
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 88
(124)I-huA33 antibody PET of colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011 Academic Article GET IT
Times cited: 84
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 70
Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 78
Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. Journal of surgical oncology. 2010 Information Resource GET IT
Times cited: 45
Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection. Critical reviews in oncology/hematology. 2010 Information Resource GET IT
Times cited: 45
The management of resectable and unresectable liver metastases from colorectal cancer. Current opinion in oncology. 2010 Information Resource GET IT
Times cited: 84
Improving response and outcomes for patients with liver-limited metastatic colorectal cancer. Clinical colorectal cancer. 2010 Information Resource GET IT
Times cited: 3
Role of adjuvant therapy after resection of colorectal cancer liver metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Information Resource GET IT
Times cited: 78
Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver. Seminars in oncology. 2010 Information Resource GET IT
Times cited: 29
Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer. 2010 Academic Article GET IT
Times cited: 168
Nasal septum perforation and bevacizumab. Medical oncology (Northwood, London, England). 2010 Article GET IT
Times cited: 9
Implanted hepatic arterial infusion pumps. Cancer journal (Sudbury, Mass.). 2010 Information Resource GET IT
Times cited: 15
Long-term outcome of unresectable metastatic colorectal cancer: does "adjuvant" chemotherapy play a role after resection?. Annals of surgery. 2009 Article GET IT
Times cited: 2
KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases. Annals of surgical oncology. 2009 Academic Article GET IT
Times cited: 166
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 367
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. The Annals of thoracic surgery. 2009 Academic Article GET IT
Times cited: 188
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 297
Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance. Molecular cancer therapeutics. 2009 Academic Article GET IT
Times cited: 51
The role of floxuridine in metastatic liver disease. Molecular cancer therapeutics. 2009 Information Resource GET IT
Times cited: 85
A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies. Cancer chemotherapy and pharmacology. 2009 Academic Article GET IT
Times cited: 18
A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer. Molecular therapy : the journal of the American Society of Gene Therapy. 2008 Academic Article GET IT
Times cited: 77
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases. Surgical oncology clinics of North America. 2008 Information Resource GET IT
Times cited: 32
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of surgery. 2008 Academic Article GET IT
Times cited: 823
Regional chemotherapy for liver-limited metastatic colorectal cancer. Clinical colorectal cancer. 2008 Information Resource GET IT
Times cited: 33
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases. Journal of surgical oncology. 2008 Academic Article GET IT
Times cited: 25
Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Annals of surgery. 2008 Academic Article GET IT
Times cited: 204
Advances in neoadjuvant therapy for colorectal cancer with liver metastases. Cancer treatment reviews. 2008 Information Resource GET IT
Times cited: 28
Second-line management of metastatic colorectal cancer. Clinical colorectal cancer. 2008 Information Resource GET IT
Times cited: 5
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 66
Actual 10-year survival after resection of colorectal liver metastases defines cure. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 1080
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 400
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology. 2007 Academic Article GET IT
Times cited: 18
Presurgical chemotherapy in patients being considered for liver resection. The oncologist. 2007 Information Resource GET IT
Times cited: 86
Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. Journal of the American College of Surgeons. 2007 Academic Article GET IT
Times cited: 191
Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. Journal of the American College of Surgeons. 2007 Academic Article GET IT
Times cited: 167
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver. Human gene therapy. 2006 Academic Article GET IT
Times cited: 160
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Annals of surgical oncology. 2006 Academic Article GET IT
Times cited: 163
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Information Resource GET IT
Times cited: 1430
Management of liver metastases from colorectal cancer. Oncology (Williston Park, N.Y.). 2006 Information Resource GET IT
Times cited: 125
Arterial embolization for salvage of hepatic artery infusion pumps. Journal of vascular and interventional radiology : JVIR. 2006 Academic Article GET IT
Times cited: 20
Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases. Diseases of the colon and rectum. 2006 Article GET IT
Times cited: 1
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 409
Regional and systemic chemotherapy for primary hepatobiliary cancers and for colorectal cancer metastatic to the liver. Seminars in radiation oncology. 2005 Information Resource GET IT
Times cited: 17
Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clinical colorectal cancer. 2005 Information Resource GET IT
Times cited: 38
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors. Cancer chemotherapy and pharmacology. 2005 Academic Article GET IT
Times cited: 23
Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. Journal of surgical oncology. 2005 Academic Article GET IT
Times cited: 56
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 229
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. Journal of the American College of Surgeons. 2005 Academic Article GET IT
Times cited: 182
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Information Resource GET IT
Times cited: 310
Hepatic arterial infusion after liver resection. The New England journal of medicine. 2005 Article GET IT
Times cited: 241
Metastases to the breast from primary pancreatic cancer. The breast journal. 2005 Article GET IT
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 64
Persistent CEA elevation in a patient with psoriasis and a history of metastatic colorectal cancer with no evidence of residual tumor. Digestive diseases and sciences. 2004 Academic Article GET IT
Times cited: 2
Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy. Journal of surgical oncology. 2004 Academic Article GET IT
Times cited: 8
Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004 Article GET IT
Times cited: 84
Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification. Cancer biology & therapy. 2004 Academic Article GET IT
Times cited: 46
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer. Anti-cancer drugs. 2004 Academic Article GET IT
Times cited: 8
Systemic or regional chemotherapy for liver metastases from colorectal cancer: has the wheel stopped spinning?. Cancer journal (Sudbury, Mass.). 2004 Information Resource GET IT
Times cited: 4
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 127
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 67
Phase I study of anticolon cancer humanized antibody A33. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
Times cited: 89
Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
Times cited: 40
Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 82
An update on hepatic arterial infusion chemotherapy for colorectal cancer. The oncologist. 2003 Information Resource GET IT
Times cited: 121
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2003 Academic Article GET IT
Times cited: 298
Molecular therapies for colorectal cancer metastatic to the liver. Molecular therapy : the journal of the American Society of Gene Therapy. 2002 Information Resource GET IT
Times cited: 22
Intrahepatic arterial infusion of chemotherapy: clinical results. Seminars in oncology. 2002 Information Resource GET IT
Times cited: 42
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 22
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Annals of surgical oncology. 2001 Academic Article GET IT
Times cited: 112
Hepatic-arterial chemotherapy. The Lancet. Oncology. 2001 Information Resource GET IT
Times cited: 66
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 193
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2001 Academic Article GET IT
Times cited: 45
Hepatic arterial therapy for the treatment of metastatic colorectal cancer. Seminars in oncology. 2000 Information Resource GET IT
Times cited: 6
Intra-abdominal fibrosis after systemic and intraperitoneal therapy containing fluoropyrimidines. Cancer. 2000 Article GET IT
Times cited: 5
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer research. 2000 Academic Article GET IT
Times cited: 89
Genes and viruses in hepatobiliary neoplasia. Seminars in surgical oncology. 2000 Information Resource GET IT
Times cited: 33
Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma. Seminars in surgical oncology. 2000 Information Resource GET IT
Times cited: 13
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. The New England journal of medicine. 1999 Academic Article GET IT
Times cited: 919
Non-surgical treatment for liver metastases. Bailliere's best practice & research. Clinical gastroenterology. 1999 Information Resource GET IT
Times cited: 12
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer. 1999 Article GET IT
Times cited: 94
Hepatic arterial chemotherapy in metastatic colorectal patients. Seminars in oncology. 1999 Information Resource GET IT
Times cited: 62
Introduction: colorectal cancer: past accomplishments and future directions I. Seminars in oncology. 1999 Academic Article GET IT
Times cited: 2
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. American journal of surgery. 1999 Academic Article GET IT
Times cited: 253
Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer. 1999 Academic Article GET IT
Times cited: 69
Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. Journal of hepato-biliary-pancreatic surgery. 1999 Information Resource GET IT
Times cited: 81
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 44
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases. Diseases of the colon and rectum. 1998 Academic Article GET IT
Times cited: 13
Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases. International journal of radiation oncology, biology, physics. 1998 Academic Article GET IT
Times cited: 4
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 98
1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Information Resource GET IT
Times cited: 145
Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma. Cancer investigation. 1998 Academic Article GET IT
Times cited: 11
Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Annals of surgical oncology. 1998 Academic Article GET IT
Times cited: 51
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma. Cancer. 1997 Academic Article GET IT
Times cited: 32
Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluorouracil and leucovorin--a case report. Cancer. 1997 Article GET IT
Times cited: 34
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Diseases of the colon and rectum. 1997 Academic Article GET IT
Times cited: 241
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. International journal of radiation oncology, biology, physics. 1997 Academic Article GET IT
Times cited: 161
Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage. Journal of vascular and interventional radiology : JVIR. 1997 Academic Article GET IT
Times cited: 22
Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?. European journal of cancer (Oxford, England : 1990). 1996 Information Resource GET IT
Times cited: 25
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 140
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. Journal of the National Cancer Institute. 1996 Information Resource GET IT
Times cited: 684
Colorectal cancer--an undertreated disease. Anti-cancer drugs. 1996 Information Resource GET IT
Times cited: 9
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 162
Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1996 Academic Article GET IT
Times cited: 20
Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1996 Academic Article GET IT
Times cited: 36
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 331
Adjuvant Chemotherapy of Colorectal Cancer. The oncologist. 1996 Academic Article GET IT
Treatment of colorectal cancer: hepatic metastasis. Seminars in surgical oncology. 1996 Information Resource GET IT
Times cited: 163
Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 1995 Academic Article GET IT
Times cited: 24
Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Article GET IT
Times cited: 8
Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer. Cancer. 1995 Academic Article GET IT
Times cited: 22
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Cancer investigation. 1995 Academic Article GET IT
Times cited: 13
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance. Cancer. 1994 Academic Article GET IT
Times cited: 14
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 175
Chemotherapy for colorectal cancer. The New England journal of medicine. 1994 Article GET IT
Times cited: 4
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer. 1994 Academic Article GET IT
Times cited: 73
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 150
Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 35
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer. 1994 Academic Article GET IT
Times cited: 129
Transport limits cellular entry of hepatic arterially injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumors. Drug metabolism and disposition: the biological fate of chemicals. 1994 Academic Article GET IT
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer. 1993 Academic Article GET IT
Times cited: 110
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. International journal of radiation oncology, biology, physics. 1993 Academic Article GET IT
Times cited: 61
A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer. 1993 Academic Article GET IT
Times cited: 56
Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin. Cancer. 1993 Academic Article GET IT
Times cited: 37
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 77
Recent advances in the treatment of advanced colorectal cancer. Cancer. 1993 Information Resource GET IT
Times cited: 71
Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer research. 1992 Academic Article GET IT
Times cited: 85
Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer. 1992 Academic Article GET IT
Times cited: 180
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 191
Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1992 Academic Article GET IT
Times cited: 164
Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 20
Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience. Seminars in oncology. 1992 Academic Article GET IT
Times cited: 14
Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: a review. Seminars in oncology. 1992 Information Resource GET IT
Times cited: 17
Overview of N-(phosphonacetyl)-L-aspartate + fluorouracil in clinical trials. Seminars in oncology. 1992 Information Resource GET IT
Times cited: 4
Review of regional therapy of liver metastases in colorectal cancer. Seminars in oncology. 1992 Information Resource GET IT
Times cited: 39
Type Ia glycogenosis associated with hepatocellular carcinoma. Cancer. 1992 Article GET IT
Times cited: 25
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. Cancer. 1992 Academic Article GET IT
Times cited: 60
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 1992 Academic Article GET IT
Times cited: 242
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 241
Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!. Important advances in oncology. 1992 Information Resource GET IT
Times cited: 36
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer. International journal of radiation oncology, biology, physics. 1992 Academic Article GET IT
Times cited: 21
A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA). Annals of internal medicine. 1991 Article GET IT
Times cited: 19
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer. 1991 Academic Article GET IT
Times cited: 87
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity. Cancer. 1990 Academic Article GET IT
Times cited: 135
Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Academic Article GET IT
Times cited: 114
A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma. Cancer. 1990 Academic Article GET IT
Times cited: 68
Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer. 1990 Academic Article GET IT
Times cited: 59
Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Academic Article GET IT
Times cited: 109
Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity. Cancer investigation. 1990 Academic Article GET IT
Times cited: 5
Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma. Cancer. 1989 Academic Article GET IT
Times cited: 12
Synchronous colon and renal cancers: six cases of a clinical entity. The American journal of medicine. 1989 Article GET IT
Times cited: 24
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine. Journal of the National Cancer Institute. 1989 Academic Article GET IT
Times cited: 25
Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer. Cancer research. 1989 Academic Article GET IT
Times cited: 11
Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates. Cancer. 1989 Academic Article GET IT
Times cited: 14
Regional treatment of hepatic metastases and hepatocellular carcinoma. Current problems in cancer. 1989 Information Resource GET IT
Times cited: 35
Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil. Cancer. 1988 Article GET IT
Times cited: 44
Localization of radioiodinated monoclonal antibody in colorectal cancer. Initial dosimetry results. Archives of surgery (Chicago, Ill. : 1960). 1987 Academic Article GET IT
Times cited: 19
Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein. Archives of surgery (Chicago, Ill. : 1960). 1987 Academic Article GET IT
Times cited: 49
A complication of prolonged infusional chemotherapy masquerading as a bone metastasis in a patient with colorectal carcinoma. Cancer. 1987 Article GET IT
Times cited: 2
Role of chemotherapy in the treatment of colorectal carcinoma. Seminars in surgical oncology. 1987 Information Resource GET IT
Times cited: 74
Systemic absorption of a leucovorin mouth wash: a pharmacologic study. Cancer investigation. 1987 Academic Article GET IT
Times cited: 4
Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer. The American journal of gastroenterology. 1986 Academic Article GET IT
Times cited: 44
Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Archives of surgery (Chicago, Ill. : 1960). 1984 Academic Article GET IT
Times cited: 128
Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1984 Academic Article GET IT
Times cited: 42
Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 7
The systemic chemotherapy of hepatic metastases. Seminars in oncology. 1983 Information Resource GET IT
Times cited: 73
Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count. The American journal of medicine. 1983 Academic Article GET IT
Times cited: 124
Phase II trial of bisantrene in advanced colorectal carcinoma. Cancer treatment reports. 1983 Academic Article GET IT
Times cited: 5
Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep). Cancer. 1983 Academic Article GET IT
Times cited: 29
Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1982 Academic Article GET IT
Times cited: 206
Randomized trial of standard therapy with or without poly I:C in patients with superficial bladder cancer. Cancer. 1981 Academic Article GET IT
Times cited: 26
Malignant thymoma: renal metastases responding to cis-platinum. Cancer. 1981 Article GET IT
Times cited: 31
Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation. Cancer. 1980 Academic Article GET IT
Times cited: 84
Phase II evaluation of N-(phosphonacetyl-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma. Cancer treatment reports. 1980 Academic Article GET IT
Times cited: 16
Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma. Cancer treatment reports. 1979 Academic Article GET IT
Times cited: 9
Phase II evaluation of vindesine in patients with advanced colorectal carcinoma. Cancer treatment reports. 1979 Academic Article GET IT
Times cited: 5

more ...

less ...

Background

education and training

M.D., New Jersey Medical School, University of Medicine and Dentistry of New Jersey 1971
B.A., University of Pennsylvania 1967

Contact

full name

Nancy Ellen Kemeny

VIVO Weill Cornell Medical College

Nancy Ellen Kemeny Professor Emerita of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name